Teratogenicity of valproic acid and related substances in the mouse: drug accumulation and pHi in the embryo during organogenesis and structure-activity considerations.
D000818:Animals; D004622:Embryo, Mammalian / Q000187:drug effects / Q000378:metabolism*; D005229:Fatty Acids, Monounsaturated; D005231:Fatty Acids, Unsaturated / Q000097:blood; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D051379:Mice; D011485:Protein Binding; D013723:Teratogens / Q000097:blood; D014635:Valproic Acid / Q000097:blood / Q000633:toxicity*
D005229:Fatty Acids, Monounsaturated; D005231:Fatty Acids, Unsaturated; D013723:Teratogens; C014168:2-propyl-2-pentenoic acid; D014635:Valproic Acid